13F
中

FBRX FORTE BIOSCIENCES INC

2026Q1 · CUSIP 34962G208 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
67
Δ holders QoQ
+8
Breadth percentile
Top 34%
Whale holders
41
Δ whales
+6
Inst. holding value
$350M
New positions
18
Closed positions
10
Price momentum (1Q)
-29.6%
Put / Call
1/2

Breadth history (34 quarters)

2024Q4: Δ+2 · h=27 2025Q1: Δ+3 · h=30 2025Q2: Δ+5 · h=35 2025Q3: Δ+7 · h=42 2025Q4: Δ+17 · h=59 2026Q1: Δ+8 · h=67 2024Q4: holders=27 2025Q1: holders=30 2025Q2: holders=35 2025Q3: holders=42 2025Q4: holders=59 2026Q1: holders=67 -17 -8.5 +0 +8.5 +17 244871 24Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
1
QoQ: +1
Call holders
2
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-4.58
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.21 2022-09-30: EPS -0.18 2022-12-31: EPS -0.24 2023-03-31: EPS -0.32 2023-06-30: EPS -0.42 2023-09-30: EPS -6.57 2023-12-31: EPS -17.61 2024-03-31: EPS -4.03 2024-06-30: EPS -6.78 2024-09-30: EPS -4.54 2024-12-31: EPS 3.18 2025-03-31: EPS -1.37 2025-06-30: EPS -0.96 2025-09-30: EPS -0.99 2025-12-31: EPS -1.39 2026-03-31: EPS -1.24 -19.37 -7.94 3.50 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)